|
KMID : 0882420240990020078
|
|
Korean Journal of Medicine
2024 Volume.99 No. 2 p.78 ~ p.83
|
|
|
Recent Progression of Incretin-Based Obesity Treatment
|
|
Choi Dug-Hyun
|
|
|
Abstract
|
|
|
|
Incretin-based obesity treatments are making remarkable progress, marking a new era in the field of obesity pharmacotherapy. These treatments not only meet the long-standing demands for safety and sustainability in obesity medications but also go beyond, significantly improving complications associated with obesity, such as cardiovascular diseases. This review explores the advancement in obesity treatments through the latest research findings on semaglutide and tirzepatide, two incretin-based obesity treatments currently receiving considerable attention.
|
|
|
KEYWORD
|
|
|
Obesity, Incretins, Glucagon-like peptide-1 receptor agonists, Glucose-dependent insulinotropic polypeptide
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|